What You Should Know:
– BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that began in 2022 when Sanofi selected the BrightInsight Platform to accelerate the development of a SaMD for one of its specialty care medicines.
– The goal of the collaboration aims to accelerate Sanofi’s drug development timeline and improve patient outcomes through innovative digital health solutions.
Accelerating Time-to-Market for New Therapies
Sanofi aims to cut its drug development timeline in half, and this partnership with BrightInsight will play a key role in achieving that goal. By leveraging BrightInsight’s platform and technology, Sanofi can streamline the development and deployment of digital health solutions that support clinical trials, enhance patient engagement, and improve medication adherence.
Enhancing Patient Experience with “MyWay”
Under the expanded partnership, Sanofi will utilize BrightInsight’s “MyWay” mobile application, a Software as a Medical Device (SaMD) solution designed to empower patients in managing their health conditions. MyWay offers several key features:
- Symptom Tracking: Allows patients to track their symptoms, such as flares or disease progression.
- Medication Management: Helps patients manage their medications, including tracking injections and adherence.
- Financial Tracking: Enables patients to track medical expenses in select countries.
- Care Team Communication: Facilitates direct communication with healthcare providers.
- Seamless User Experience: Provides a user-friendly and intuitive platform for managing health.
“Sanofi is recognized globally for the transformational therapies that they develop and their impact on patient lives, and BrightInsight is honored to serve as one of their digital partners to drive value for those therapies,” said Kal Patel, MD, CEO and Co-Founder, BrightInsight. “The robustness of our BrightInsight Platform and Disease Management Solution enables Sanofi to quickly launch and scale companion apps across different brands and markets, configuring each solution to specific disease populations and market requirements in a fast, patient-centric, and compliant manner globally.”